| Business Summary | | Quest
Diagnostics
Incorporated
is
a
provider
of
diagnostic
testing
and
related
services
for
the
healthcare
industry.
The
Company
offers
a
broad
range
of
clinical
laboratory
testing
services
used
by
physicians
in
the
detection,
diagnosis,
evaluation,
monitoring
and
treatment
of
diseases
and
other
medical
conditions.
The
Company
is
engaged
in
clinical
laboratory
testing
and
esoteric
testing,
including
molecular
diagnostics,
as
well
as
anatomic
pathology
services
and
testing
for
drugs
of
abuse.
The
Company
has
a
network
of
principal
laboratories
located
in
approximately
30
metropolitan
areas
throughout
the
United
States,
several
joint-venture
laboratories
and
approximately
150
smaller
rapid-response
laboratories
and
1,300
patient
service
centers.
The
Company
also
operates
an
esoteric
testing
laboratory
and
development
facility,
known
as
Nichols
Institute,
located
in
San
Juan
Capistrano,
California,
as
well
as
laboratory
facilities
in
Mexico
City,
Mexico
and
near
London,
England. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Quest
Diagnostics
is
a
clinical
laboratory
testing
company
which
offers
testing
services
used
by
the
medical
profession
in
the
detection,
diagnosis,
monitoring
and
treatment
of
diseases.
For
the
six
months
ended
6/30/01,
net
revenues
increased
5%
to
$1.81
billion.
Net
income
before
extraordinary
item
rose
73%
to
$82.9
million.
Revenues
reflect
improved
pricing
on
manage
care
business
and
acquisitions.
Earnings
also
benefitted
from
improved
margins
and
lower
interest
expense. | More
from
Market Guide: Significant
Developments |
| | | | FY1999
Compensation | | Pay | Exer | |
| Kenneth Freeman, 49 Chairman
and CEO | $5.9M | $197K | Surya Mohapatra, Ph.D., 50 Pres
and COO | 2.5M | -- | Vijay Aggarwal, 50 Pres
of Quest Diagnostics Ventures | -- | -- | Robert Hagemann, 43 Corp.
VP and CFO | 1.0M | -- | Joseph Manory VP,
Treasurer | -- | -- | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|